Skip to main content
. Author manuscript; available in PMC: 2020 Dec 8.
Published in final edited form as: Am J Reprod Immunol. 2020 Jul 1;84(4):e13288. doi: 10.1111/aji.13288

Table 1.

Characteristics of study participants

Maternal age (year) 33 ± 5
Gestational age at delivery (week) 38 ± 5

Race/Ethnicity
White 6 (27)
Black 2 (9)
Asian 2 (9)
Multi-racial 1 (5)
Unknown/Other 11 (50)
Hispanic 11 (50)

Clinical Zika testing
Negative 8 (36)
Positive 3 (14)
Unknown/declined 11 (50)

Gestational Age at Exposure
Preconception 13 (59)
First trimester 16 (72)
Second trimester 9 (41)
Third trimester 3 (14)

Exposure type
Living in high transmission area 9 (41)
Travel to high transmission area 14 (64)
Sexual exposure 16 (73)

Exposure region
North America 5 (23)
Caribbean 11 (50)
Central America 1 (5)
South America 6 (27)
Africa/Cape Verde 1 (5)
Asia/Pacific Islands 0

Infection history
Symptoms of Zika infection 3 (14)
Prior non-Zika flavivirus infection 2 (9)

Vaccine history
Yellow fever vaccine 5 (23)

All values expressed as mean ± standard deviation or n (%)